Yi Xiao

机构：Children's Medical Center, Shanghai Medical College of Fudan University, Dalian Medical University, Guangdong Province Stomatological Hospital, Fudan University Shanghai Cancer Center, Second Affiliated Hospital of Chongqing Medical University, The University of Texas Southwestern Medical Center, Chongqing Medical University · ORCID：0000-0003-2132-9609

发表论文 49 篇 · 总被引 3648 次 · h-index 23

代表论文

• Emerging therapies in cancer metabolism (2023 · Cell Metabolism · 被引 255)
• Radiomics in breast cancer: Current advances and future directions (2024 · Cell Reports Medicine · 被引 174)
• Molecular classification of hormone receptor-positive HER2-negative breast cancer (2023 · Nature Genetics · 被引 117)
• Optimising first-line subtyping-based therapy in triple-negative breast cancer (FUTURE-SUPER): a multi-cohort, randomised, phase 2 trial (2024 · The Lancet Oncology · 被引 71)
• Single-cell morphological and topological atlas reveals the ecosystem diversity of human breast cancer (2023 · Nature Communications · 被引 71)
• Subtyping-based platform guides precision medicine for heavily pretreated metastatic triple-negative breast cancer: The FUTURE phase II umbrella clinical trial (2023 · Cell Research · 被引 71)